Interestingly, this DC subset not only expressed activation markers, but they also had an Il2b signature (Figures 3C, 3D, S4G, and S4H) and expressed migratory markers, including Fscn1 and Ccr7 which are important in facilitating DC migration to tumor-draining lymph nodes to shuttle between lymph nodes and the CNS. The gene discussed is CCR7; the disease is neoplasm.